Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
Notified -
Globe Newswire24-03-2025, 10:53
Hazer Achieves First Hydrogen and Graphite at Commercial Demonstration Plant 1-02-2024, 07:01